Investors

Key press releases

04 Aug 2025
16:30 E.S.T.

Finance

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

28 Jul 2025
16:30 E.S.T.

Finance

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

26 Jun 2025
16:30 E.S.T.

Corporate

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

Key upcoming events

16 Oct 2025

Cellectis Investors R&D Day 2025

Learn more

Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).

$2.9900

0.0000 (0.0000%)

Prev. close: 2.9900
Volume: 0
High: 3.1299
Capitalization: 215.560M

€2.8500

+0.1800 (6.7416%)

Prev. close: 2.6700
Volume: 224,115
High: 2.8750
Capitalization: 205.467M

See stock information

Covering research analysts

Barclays - Gena Wang

Bryan Garnier - Oscar Haffen-Lamm

Goldman Sachs - Salveen Richter

Jefferies - Kelly Shi

JMP Securities - Silvan Tuerkcan

Jones Trading - Soumit Roy

Kempen - Sebastiaan van der Schoot

Oddo BHF - Martial Descoutures

RW Baird - Jack Allen

Wells Fargo – Yanan Zhu

Cellectis contact information

Arthur Stril, Chief Financial Officer & Chief Business Officer

investors@cellectis.com

Citibank ADR contact information

Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030

citiadr@citi.com

Société Générale Securities Services - Ordinary Shares contact information

Call center in English and French

Monday to Friday from 8:30am to 6pm CEST

+33 (0)2 51 85 67 89